Polymorphisms in NRAMP1 and hGPX1gene to BCG have resulted in decreased cancer-specific survival (CSS) for the NRAMP1 D543N G:G genotype, as well as reduced recurrence-free survival (RFS) and increased risk of recurrence post-BCG [21]. Here, SLC11A1 is linked to cancer.